Cell-free expression systems have become a mature technology for synthesizing proteins in cell lysates. CD Formulation integrates cell-free expression technology into our internal protein production platform, offering the ultimate solution for your protein production. Our services can be tailored to your specific requirements (e.g., tag selection, purity).
Cell-free protein expression, also known as in vitro translation, cell-free translation, and cell-free protein synthesis, is a method of synthesizing proteins in vitro that can produce target proteins without the use of living cells. Because this protein synthesis occurs in cell lysates rather than in cultured cells, this method is called cell-free. This technology enables researchers to quickly express and manufacture small amounts of functional proteins. Compared to in vivo techniques in bacteria or tissue culture cells, cell-free protein expression is fast because no gene transfection, cell culture, or extensive protein purification is required.
Fig. 1 The components of a cell-free protein synthesis reaction. (Brookwell A, et al., 2021)
CD Formulation is one of the world leaders in the production of therapeutic proteins using advanced cell-free protein synthesis technology. Thanks to the innovative cell-free protein synthesis system (CFPS), we can handle difficult proteins that show no/low expression, aggregation, etc. in other systems. The expression process that originally took several days has been optimized and shortened to a few hours.
Our personalized cell-free protein synthesis service can flexibly express proteins according to the specific needs of our customers. By introducing the desired nucleotide modifications in the transcribed tRNA, we can help increase the freedom of regulation of the translation process.
Our services include but are not limited to:
Two basic components of cell-free protein expression are a genetic template (plasmid DNA, linear DNA, or mRNA) encoding the protein of interest and a reaction solution containing the necessary molecular machinery for transcription and translation.
In CFPS, our scientists use a solution containing all the cellular machinery required to direct protein synthesis to transcribe and translate the provided nucleic acid template.
Common cell extracts contain most or all of the molecules in the reaction solution, including:
Extracts from cell-free expression are made using different systems to support high levels of protein synthesis. The following table lists the common cell-free expression systems.
E. coli | Wheat Germ | Insects | Mammals | Humans | |
Yield | High | Medium | Medium-Low | High | Low |
Phosphorylation | No | Yes | Yes | Yes | Yes |
Glycosylation | No | No | Yes | Yes | Yes |
Advantages |
|
|
|
|
|
Disadvantages |
|
|
|
|
|
Published Data
Technology: Cell-Free Expression Technology
Journal: Cell Chem Biol.
IF: 6.68
Published: 2019
Results:
The authors developed a high-yield, one-pot cell-free platform for the synthesis of ncAA-bearing proteins. The platform did not require the addition of purified T7 DNA-directed RNA polymerase (T7RNAP) to catalyze transcription. The ability of extracts from the resulting transformants to catalyze CFPS in the absence of exogenous polymerase supplementation was evaluated. Finally, using the optimized one-pot platform, multisite incorporation of the ncAA acetyl-L-phenylalanine into elastin-like polypeptides was demonstrated with high accuracy and high yield.
Fig. 2 Simplified schematic of the production and utilization of crude lysates from E. coli cells to catalyze cell-free protein synthesis. (Des Soye, et al., 2019)
Thanks to our in-house advanced cell-free expression platform, CD Formulation is committed to providing efficient and economical production of therapeutic proteins. Please feel free to contact us if you are interested in our services. Learn how our cell-free expression technology can support your recombinant protein synthesis projects.
References